Harvard Bioscience
HBIO
#8962
Rank
A$0.14 B
Marketcap
$3.43
Share price
1.40%
Change (1 day)
-53.10%
Change (1 year)

Harvard Bioscience (HBIO) - Cash on Hand

Cash on Hand as of September 2024 : A$7.22 Million

According to Harvard Bioscience's latest financial reports the company has A$7.22 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Harvard Bioscience - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$6.28 M-5.1%
2022-12-31A$6.62 M-38.59%
2021-12-31A$10.78 M-0.26%
2020-12-31A$10.81 M-9.14%
2019-12-31A$11.9 M2.61%
2018-12-31A$11.6 M74.45%
2017-12-31A$6.65 M-14.34%
2016-12-31A$7.76 M-16.14%
2015-12-31A$9.25 M-46.4%
2014-12-31A$17.27 M-40.22%
2013-12-31A$28.89 M45.18%
2012-12-31A$19.9 M13.89%
2011-12-31A$17.47 M-9.92%
2010-12-31A$19.39 M5.05%
2009-12-31A$18.46 M-4.89%
2008-12-31A$19.41 M-5.11%
2007-12-31A$20.46 M72.38%
2006-12-31A$11.86 M13.8%
2005-12-31A$10.43 M-41.79%
2004-12-31A$17.91 M61.98%
2003-12-31A$11.06 M-59.3%
2002-12-31A$27.17 M-52.8%
2001-12-31A$57.57 M-10.12%
2000-12-31A$64.06 M1656.86%
1999-12-31A$3.64 M133.29%
1998-12-31A$1.56 M